Outlook Therapeutics Raises $5M via Direct Offering to Largest Shareholder
Outlook Therapeutics raises $5M through direct offering of 8.5M shares at $0.5855 to largest shareholder GMS Ventures, with warrant price amendment.
OTLKcapital raiseregistered direct offering